1-3 of 3
Naoshi Sugimoto
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Production and nonclinical evaluation of an autologous iPSC–derived platelet product for the iPLAT1 clinical trial

Naoshi Sugimoto, Sou Nakamura, Shin Shimizu, Akiko Shigemasa, Junya Kanda, Nobuki Matsuyama, Mitsunobu Tanaka, Tomoya Hayashi, Akihiro Fuchizaki, Masayuki Nogawa, Naohide Watanabe, Shinichiro Okamoto, Makoto Handa, Akira Sawaguchi, Dai Momose, Ki-Ryang Koh, Yoshihiko Tani, Akifumi Takaori-Kondo, Koji Eto
Journal: Blood Advances
Blood Adv (2022) 6 (23): 6056–6069.
https://doi.org/10.1182/bloodadvances.2022008512
Published: 2022
Includes: Multimedia, Supplemental data
Journal Articles

A β1-tubulin–based megakaryocyte maturation reporter system identifies novel drugs that promote platelet production

Hideya Seo, Si Jing Chen, Kazuya Hashimoto, Hiroshi Endo, Yohei Nishi, Akira Ohta, Takuya Yamamoto, Akitsu Hotta, Akira Sawaguchi, Hideki Hayashi, Noritaka Koseki, George J. Murphy, Kazuhiko Fukuda, Naoshi Sugimoto, Koji Eto
Journal: Blood Advances
Blood Adv (2018) 2 (17): 2262–2272.
https://doi.org/10.1182/bloodadvances.2018019547
Published: 2018
Includes: Supplemental data
Journal Articles

Novel TPO receptor agonist TA-316 contributes to platelet biogenesis from human iPS cells

Ayako Aihara, Tomo Koike, Natsuki Abe, Sou Nakamura, Akira Sawaguchi, Takanori Nakamura, Naoshi Sugimoto, Hiromitsu Nakauchi, Taito Nishino, Koji Eto
Journal: Blood Advances
Blood Adv (2017) 1 (7): 468–476.
https://doi.org/10.1182/bloodadvances.2016000844
Published: 2017
Includes: Supplemental data